Canaccord Genuity initiated coverage of Claritev (NYSE:CTEV) with a Buy rating on May 29, 2026. The analyst’s price forecast implies 65.29% upside, signaling constructive expectations for the stock’s fundamentals. The note is positive for sentiment but is still an analyst initiation rather than a company-reported operating update.
Canaccord Genuity initiated coverage of Claritev (NYSE:CTEV) with a Buy rating on May 29, 2026. The analyst’s price forecast implies 65.29% upside, signaling constructive expectations for the stock’s fundamentals. The note is positive for sentiment but is still an analyst initiation rather than a company-reported operating update.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.32
Ticker Sentiment